Acute Coronary Syndrome PPT
Links shared publicly online about this topic
Bayer, J&J answer FDA query over wider Xarelto use | Yahoo! Health
health.yahoo.net — “FRANKFURT (Reuters) - Bayer said its development partner Johnson & Johnson filed a response to U.S. regulators' concerns over a new use for their Xarelto anti-clotting pill to prevent heart attacks and strokes in patients with acute coronary syndrome (ACS). The U.S.” View full resource at health.yahoo.net
Most Recently Shared on September 7, 2012 at 12:27 pm By:
Jane Anderson Healthy Eating Advisor
Bayer, J&J answer FDA query over wider Xarelto use http://t.co/oS8ebOBi
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
Advertisement
